CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study
Ki Sun Jung, Su Jin Lee, Se Hoon Park, Jae-Lyun Lee, Se-Hoon Lee, Jae Yun Lim, Jung Hun Kang, Suee Lee, Sun Young Rha, Kyung Hee Lee, Ho Young Kim, Ho Yeong Lim
Cancer Research and Treatment. 2018;50(2):488-494.   Published online 2017 May 22    DOI:

Excel Download

Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study
Cancer Research and Treatment. 2018;50(2):488-494   Crossref logo
Link1 Link2 Link3

A Study of Pazopanib Safety and Efficacy in Patients With Advanced Clear Cell Renal Cell Carcinoma and ECOG Performance Status 2 (Pazo2): An Open label, Multicentre, Single Arm, Phase II Trial
Clinical Genitourinary Cancer. 2022;   Crossref logo
Link1 Link2

Treatment for Non-clear Cell Renal Cell Carcinoma
Renal Cell Carcinoma. 2017;319-332   Crossref logo

A Multicenter Phase II Trial of Axitinib in Patients With Recurrent or Metastatic Non–clear-cell Renal Cell Carcinoma Who Had Failed Prior Treatment With Temsirolimus
Clinical Genitourinary Cancer. 2018;16(5):e997-e1002   Crossref logo
Link1 Link2

A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma
European Urology. 2021;80(2):162-170   Crossref logo
Link1 Link2

Diseases of the Esophagus. 2021;34(Supplement_1):   Crossref logo
Link1 Link2

Efficacy and Safety of Oral Topotecan and Bevacizumab Combination as Second-Line Treatment for Relapsed Small-Cell Lung Cancer: An Open-Label Multicenter Single-Arm Phase II Study
Clinical Lung Cancer. 2013;14(4):356-363   Crossref logo
Link1 Link2

Safety and Efficacy of PF-3512676 for the Treatment of Stage IV Renal Cell Carcinoma: An Open-Label, Multicenter Phase I/II Study
Clinical Genitourinary Cancer. 2009;7(3):E58-E65   Crossref logo
Link1 Link2

<p>Intercalated combination of chemotherapy and erlotinib for stage IIIA non-small-cell lung cancer: a multicenter, open-label, single-arm, phase II study</p>
Cancer Management and Research. 2019;Volume 11:6543-6552   Crossref logo
Link1 Link2

Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of metastatic renal cell carcinoma (SWITCH-II)
Annals of Oncology. 2017;28:v295   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.